Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 8 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9AT46
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.621 |
CLV_NRD_NRD_1 | 194 | 196 | PF00675 | 0.581 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.531 |
CLV_NRD_NRD_1 | 274 | 276 | PF00675 | 0.452 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.627 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.578 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.495 |
CLV_PCSK_FUR_1 | 140 | 144 | PF00082 | 0.646 |
CLV_PCSK_FUR_1 | 272 | 276 | PF00082 | 0.425 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.584 |
CLV_PCSK_KEX2_1 | 194 | 196 | PF00082 | 0.383 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.531 |
CLV_PCSK_KEX2_1 | 274 | 276 | PF00082 | 0.449 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.627 |
CLV_PCSK_KEX2_1 | 37 | 39 | PF00082 | 0.578 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.495 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.655 |
DEG_SPOP_SBC_1 | 60 | 64 | PF00917 | 0.662 |
DEG_SPOP_SBC_1 | 80 | 84 | PF00917 | 0.677 |
DOC_CYCLIN_RxL_1 | 89 | 97 | PF00134 | 0.683 |
DOC_PP1_RVXF_1 | 272 | 279 | PF00149 | 0.454 |
DOC_PP2B_PxIxI_1 | 121 | 127 | PF00149 | 0.445 |
DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.691 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.708 |
DOC_USP7_MATH_1 | 282 | 286 | PF00917 | 0.630 |
DOC_USP7_MATH_1 | 306 | 310 | PF00917 | 0.668 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.581 |
DOC_USP7_MATH_2 | 305 | 311 | PF00917 | 0.754 |
DOC_WW_Pin1_4 | 263 | 268 | PF00397 | 0.505 |
DOC_WW_Pin1_4 | 74 | 79 | PF00397 | 0.680 |
LIG_14-3-3_CanoR_1 | 163 | 169 | PF00244 | 0.420 |
LIG_14-3-3_CanoR_1 | 220 | 228 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 255 | 259 | PF00244 | 0.510 |
LIG_Actin_WH2_2 | 40 | 57 | PF00022 | 0.650 |
LIG_BIR_III_4 | 237 | 241 | PF00653 | 0.361 |
LIG_BRCT_BRCA1_1 | 164 | 168 | PF00533 | 0.331 |
LIG_BRCT_BRCA1_1 | 204 | 208 | PF00533 | 0.282 |
LIG_Clathr_ClatBox_1 | 115 | 119 | PF01394 | 0.473 |
LIG_deltaCOP1_diTrp_1 | 235 | 243 | PF00928 | 0.331 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.308 |
LIG_FHA_1 | 260 | 266 | PF00498 | 0.445 |
LIG_FHA_1 | 296 | 302 | PF00498 | 0.665 |
LIG_FHA_2 | 247 | 253 | PF00498 | 0.440 |
LIG_FHA_2 | 81 | 87 | PF00498 | 0.564 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.637 |
LIG_LIR_Gen_1 | 3 | 10 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 3 | 9 | PF02991 | 0.680 |
LIG_Pex14_2 | 244 | 248 | PF04695 | 0.490 |
LIG_Pex14_2 | 4 | 8 | PF04695 | 0.426 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.361 |
LIG_SH3_3 | 104 | 110 | PF00018 | 0.670 |
LIG_SH3_3 | 261 | 267 | PF00018 | 0.428 |
LIG_SH3_3 | 276 | 282 | PF00018 | 0.599 |
LIG_SUMO_SIM_par_1 | 113 | 119 | PF11976 | 0.464 |
LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.418 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.745 |
MOD_CK1_1 | 171 | 177 | PF00069 | 0.318 |
MOD_CK1_1 | 251 | 257 | PF00069 | 0.396 |
MOD_CK1_1 | 67 | 73 | PF00069 | 0.684 |
MOD_CK2_1 | 282 | 288 | PF00069 | 0.569 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.732 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.633 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.729 |
MOD_GlcNHglycan | 158 | 162 | PF01048 | 0.516 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.416 |
MOD_GlcNHglycan | 212 | 216 | PF01048 | 0.561 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.710 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.700 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.527 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.401 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.305 |
MOD_GSK3_1 | 244 | 251 | PF00069 | 0.488 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.447 |
MOD_GSK3_1 | 295 | 302 | PF00069 | 0.651 |
MOD_GSK3_1 | 307 | 314 | PF00069 | 0.623 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.645 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.684 |
MOD_N-GLC_1 | 168 | 173 | PF02516 | 0.522 |
MOD_N-GLC_1 | 295 | 300 | PF02516 | 0.604 |
MOD_N-GLC_2 | 189 | 191 | PF02516 | 0.561 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.731 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.481 |
MOD_NEK2_1 | 178 | 183 | PF00069 | 0.336 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.488 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.618 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.650 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.627 |
MOD_NEK2_2 | 239 | 244 | PF00069 | 0.391 |
MOD_NEK2_2 | 282 | 287 | PF00069 | 0.647 |
MOD_PIKK_1 | 311 | 317 | PF00454 | 0.694 |
MOD_PKA_2 | 162 | 168 | PF00069 | 0.411 |
MOD_PKA_2 | 254 | 260 | PF00069 | 0.556 |
MOD_PKA_2 | 54 | 60 | PF00069 | 0.632 |
MOD_Plk_1 | 251 | 257 | PF00069 | 0.387 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.697 |
MOD_Plk_4 | 178 | 184 | PF00069 | 0.361 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.290 |
MOD_Plk_4 | 239 | 245 | PF00069 | 0.290 |
MOD_Plk_4 | 260 | 266 | PF00069 | 0.423 |
MOD_ProDKin_1 | 263 | 269 | PF00069 | 0.509 |
MOD_ProDKin_1 | 74 | 80 | PF00069 | 0.680 |
TRG_DiLeu_BaEn_1 | 49 | 54 | PF01217 | 0.613 |
TRG_DiLeu_BaLyEn_6 | 90 | 95 | PF01217 | 0.588 |
TRG_ER_diArg_1 | 139 | 142 | PF00400 | 0.654 |
TRG_ER_diArg_1 | 193 | 195 | PF00400 | 0.183 |
TRG_ER_diArg_1 | 218 | 220 | PF00400 | 0.212 |
TRG_ER_diArg_1 | 272 | 275 | PF00400 | 0.452 |
TRG_ER_diArg_1 | 37 | 39 | PF00400 | 0.601 |
TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.495 |
TRG_Pf-PMV_PEXEL_1 | 92 | 97 | PF00026 | 0.682 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIJ6 | Leptomonas seymouri | 58% | 100% |
A0A1X0NM60 | Trypanosomatidae | 37% | 100% |
A0A3Q8IKT7 | Leishmania donovani | 90% | 98% |
A0A422N6R3 | Trypanosoma rangeli | 43% | 100% |
A4ICH5 | Leishmania infantum | 91% | 98% |
E9AIX8 | Leishmania braziliensis | 81% | 100% |
Q4Q1F2 | Leishmania major | 90% | 100% |
V5BPS4 | Trypanosoma cruzi | 43% | 100% |